journal article·2024-08-31Open access

Novel Chitosan-Gelatin Scaffold with Valproic Acid Augments In Vitro Osteoblast Differentiation of Mesenchymal Stem Cells

Maha Alghofaily, Fahd Alsalleeh, Lamees Alssum, Manikandan Muthurangan, Musaad Alfayez, Michael D. Weir, Hockin H. K. Xu

Abstract

The study aimed to develop a biodegradable scaffold incorporating valproic acid (VPA) for improved human bone marrow-derived mesenchymal stem cell (hBMSC) proliferation, differentiation, and bone mineral synthesis. A chitosan–gelatin (CH-G) scaffold was fabricated and loaded with varying concentrations of VPA (1, 3, 5 mM/L). In vitro studies assessed drug release, cell proliferation, morphology, mineralization, and gene expression. VPA was rapidly released from the scaffold, with over 90% cumulative release within seven days. Cells cultured on VPA-loaded scaffolds exhibited significantly enhanced proliferation and mineralization compared to the control. VPA treatment upregulated osteocalcin and runt-related transcription factor 2 (Runx-2) expression, key markers of osteogenic differentiation. The CH-G scaffold, particularly with 1 mM/L VPA, demonstrates excellent biocompatibility and promotes hBMSC-mediated bone regeneration. This novel approach holds promise for future applications in bone tissue engineering.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Histone Deacetylase Inhibitors Research · Graphene and Nanomaterials Applications · Bone Tissue Engineering Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Restorative Dental Sciences, College of Dentistry, King Saud University, Riyadh 11541, Saudi Arabia

Department of Periodontics and Community Dentistry, College of Dentistry, King Saud University, Riyadh 11545, Saudi Arabia

Stem Cell Unit, Department of Anatomy, College of Medicine, King Saud University, Riyadh 11461, Saudi Arabia

Department of Biomaterials and Regenerative Dental Medicine, University of Maryland School of Dentistry, Baltimore, MD 21201, USA

Funding

Researchers Supporting Project

References (35)

Show source-provided references
1. Epigenetic regulation of mesenchymal stem cells: A focus on osteogenic and adipogenic differentiation10.4061/2011/201371 ↗
2. Man, K., Lawlor, L., Jiang, L.H., and Yang, X.B. (2021). The Selective Histone Deacetylase Inhibitor MI192 Enhances the Osteogenic Differentiation Efficacy of Human Dental Pulp Stromal Cells. Int. J. Mol. Sci., 22.10.3390/ijms22105224 ↗
3. The Role of Epigenetic in Dental and Oral Regenerative Medicine by Different Types of Dental Stem Cells: A Comprehensive Overview10.1155/2022/5304860 ↗
4. Histone deacetylase (HDAC) 1 and 2 are essential for accurate cell division and the pluripotency of embryonic stem cells10.1073/pnas.1321330111 ↗
5. Chen, G., Yin, S., Zeng, H., Li, H., and Wan, X. (2022). Regulation of embryonic stem cell self-renewal. Life, 12.10.3390/life12081151 ↗
6. Effect of the Histone Deacetylases Inhibitors on the Differentiation of Stem Cells in Bone Damage Repairing and Regeneration10.2174/1574888X14666190905155516 ↗
7. HDAC inhibitor trichostatin A promotes proliferation and odontoblast differentiation of human dental pulp stem cells10.1089/ten.tea.2012.0163 ↗
8. Histone deacetylase inhibitors induced differentiation and accelerated mineralization of pulp-derived cells10.1016/j.joen.2011.12.014 ↗
9. Shnayder, N.A., Grechkina, V.V., Khasanova, A.K., Bochanova, E.N., Dontceva, E.A., Petrova, M.M., Asadullin, A.R., Shipulin, G.A., Altynbekov, K.S., and Al-Zamil, M. (2023). Therapeutic and Toxic Effects of Valproic Acid Metabolites. Metabolites, 13.10.3390/metabo13010134 ↗
10. New valproate regulations, informed choice and seizure risk10.1007/s00415-024-12436-8 ↗
11. Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells10.1158/0008-5472.CAN-04-3011 ↗
12. Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection10.2174/1874467210902010095 ↗
13. Valproic acid, A Potential Inducer of Osteogenesis in Mouse Mesenchymal Stem Cells10.2174/1874467213666200713102410 ↗
14. Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors10.1002/jcb.20544 ↗
15. Antibacterial PEG-Chitosan Hydrogels for Controlled Antibiotic/Protein Delivery10.1021/acsabm.9b00570 ↗
16. Effects of a Bioactive Scaffold Containing a Sustained Transforming Growth Factor-β1-releasing Nanoparticle System on the Migration and Differentiation of Stem Cells from the Apical Papilla10.1016/j.joen.2016.06.017 ↗
17. Alghofaily, M., Almana, A., Alrayes, J., Lambarte, R., Weir, M.D., and Alsalleeh, F. (2024). Chitosan–Gelatin Scaffolds Loaded with Different Antibiotic Formulations for Regenerative Endodontic Procedures Promote Biocompatibility and Antibacterial Activity. J. Funct. Biomater., 15.10.3390/jfb15070186 ↗
18. Chitosan-gelatin scaffolds for tissue engineering: Physico-chemical properties and biological response of buffalo embryonic stem cells and transfectant of GFP-buffalo embryonic stem cells10.1016/j.actbio.2009.05.012 ↗
19. Histone deacetylase inhibitors epigenetically promote reparative events in primary dental pulp cells10.1016/j.yexcr.2013.02.022 ↗
20. Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene despite [corrected] extensive proliferation10.1016/j.bbrc.2004.11.059 ↗
21. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells10.1038/nbt0602-592 ↗
22. NR2F1 mediated down-regulation of osteoblast differentiation was rescued by bone morphogenetic protein-2 (BMP-2) in human MSC10.1016/j.diff.2018.10.003 ↗
23. Yarahmadi, A., Dousti, B., Karami-Khorramabadi, M., and Afkhami, H. (2024). Materials based on biodegradable polymers chitosan/gelatin: A review of potential applications. Front. Bioeng. Biotechnol., 12.10.3389/fbioe.2024.1397668 ↗
24. Study on physical properties and nerve cell affinity of composite films from chitosan and gelatin solutions10.1016/S0142-9612(03)00117-0 ↗
25. The addition of biphasic calcium phosphate to porous chitosan scaffolds enhances bone tissue development in vitro
26. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone10.1016/j.ijpharm.2007.01.026 ↗
27. Stem cells immortalized by hTERT perform differently from those immortalized by SV40LT in proliferation, differentiation, and reconstruction of matrix microenvironment10.1016/j.actbio.2021.09.021 ↗
28. Establishment of human immortalized mesenchymal stem cells lines for the monitoring and analysis of osteogenic differentiation in living cells10.1016/j.heliyon.2020.e05398 ↗
29. Histone deacetylase 1-mediated histone modification regulates osteoblast differentiation10.1210/me.2006-0061 ↗
30. Effect of valproic acid on the hepatic differentiation of mesenchymal stem cells in 2D and 3D microenvironments10.1007/s11010-020-03955-9 ↗
31. Inhibition of histone acetylation as a tool in bone tissue engineering10.1089/ten.2006.12.2927 ↗
32. Histone deacetylase inhibitors promote osteoblast maturation10.1359/JBMR.050813 ↗
33. Suberoylanilide hydroxamic acid enhances odontoblast differentiation10.1177/0022034512443367 ↗
34. The histone deacetylase inhibitor, entinostat (MS-275), induces the odontogenic differentiation of an odontoblast-like cell line in the absence of an osteoblast mineralization medium10.1007/s10266-020-00588-8 ↗
35. Histone deacetylase inhibitors decrease proliferation potential and multilineage differentiation capability of human mesenchymal stem cells10.1111/j.1365-2184.2009.00633.x ↗